Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds JMP Securities Downgrades Duck Creek Technologies to Market Perform

JMP Securities Downgrades Duck Creek Technologies to Market Perform

JMP Securities analyst Joe Goodwin downgrades Duck Creek Technologies (NASDAQ:DCT) from Market Outperform to Market Perform.

byBenzinga Newsdesk

July 1, 2022

1 minute read

JMP Securities analyst Joe Goodwin downgrades Duck Creek Technologies (NASDAQ:DCT) from Market Outperform to Market Perform.

BMW Issues ‘Do Not Drive’ Warning For 90,000 Cars With Faulty Airbags: Report

By Shivani Kumaresan

May 5, 8:47 AM

BMW (Bayerische Motoren Werke ADR) (OTC: BMWYY) has reportedly issued a "do not drive" alert for the 90,000 affected sedans and SUVs with faulty airbags.

BMWYY

Analyst Ratings

Analyst Scoreboard: 5 Ratings For Recursion Pharmaceuticals

By Benzinga Insights

April 9, 10:00 AM

Throughout the last three months, 5 analysts have evaluated Recursion Pharmaceuticals (NASDAQ:RXRX), offering a diverse set of opinions…

RXRX

From Speculation To Revelation: JPMorgan Reportedly Unveils IndexGPT AI Tool

By Shivani Kumaresan

May 3, 1:43 PM

A year after sparking speculation with its trademark application for "IndexGPT," JPMorgan Chase is reportedly revealing the product's details.

Morgan Stanley Maintains Equal-Weight on CinCor Pharma, Raises Price Target to $30

By Benzinga Newsdesk

January 10, 9:53 AM

Morgan Stanley analyst Jeffrey Hung maintains CinCor Pharma (NASDAQ:CINC) with a Equal-Weight and raises the price target from $22 to $30.

CINC

JMP Securities Downgrades Duck Creek Technologies to Market Perform

Related Posts

BMW Issues ‘Do Not Drive’ Warning For 90,000 Cars With Faulty Airbags: Report

Analyst Scoreboard: 5 Ratings For Recursion Pharmaceuticals

From Speculation To Revelation: JPMorgan Reportedly Unveils IndexGPT AI Tool

Morgan Stanley Maintains Equal-Weight on CinCor Pharma, Raises Price Target to $30